MAA
ALXN

Managed Account Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Managed Account Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$222M Buy
1,227,510
+169,272
+16% +$29.2M 0.18% 146
2015
Q1 		$183M Buy
1,058,238
+174,043
+20% +$31.5M 0.16% 161
2014
Q4 		$164M Buy
884,195
+129,348
+17% +$24M 0.16% 160
2014
Q3 		$125M Buy
754,847
+10,369
+1% +$1.7M 0.14% 179
2014
Q2 		$116M Buy
744,478
+80,328
+12% +$12.7M 0.14% 178
2014
Q1 		$101M Sell
664,150
-29,395
-4% -$4.67M 0.13% 187
2013
Q4 		$92.2M Buy
693,545
+21,227
+3% +$2.55M 0.12% 204
2013
Q3 		$78.1M Sell
672,318
-99,019
-13% -$10.9M 0.11% 216
2013
Q2 		$71.1M Buy
+771,337
New +$74.3M 0.11% 219

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return